MétaCan
Menu
Back to cohort
Record W4410755510 · doi:10.1021/acs.jcim.5c00588

Active Learning-Guided Hit Optimization for the Leucine-Rich Repeat Kinase 2 WDR Domain Based on In Silico Ligand-Binding Affinities

2025· article· en· W4410755510 on OpenAlexafffund
Filipp Gusev, Evgeny Gutkin, Francesco Gentile, Fuqiang Ban, S. Benjamin Koby, Fengling Li, Irene Chau, Suzanne Ackloo, C.H. Arrowsmith, Albina Bolotokova, Pegah Ghiabi, Elisa Gibson, Levon Halabelian, Scott Houliston, Rachel Harding, Ashley Hutchinson, P. Loppnau, Sumera Perveen, Almagul Seitova, Hong Zeng, Matthieu Schapira, Artem Cherkasov, Olexandr Isayev, Maria G. Kurnikova

Bibliographic record

VenueJournal of Chemical Information and Modeling · 2025
Typearticle
Languageen
FieldComputer Science
TopicComputational Drug Discovery Methods
Canadian institutionsPrincess Margaret Cancer CentreStructural Genomics ConsortiumUniversity of TorontoUniversity Health NetworkUniversity of British ColumbiaUniversity of Ottawa
FundersDivision of ChemistryOffice of Advanced CyberinfrastructureSchool of Computer Science, Carnegie Mellon UniversityMellon College of Science, Carnegie Mellon UniversityGenentechMitacsOntario Genomics InstituteNational Institutes of HealthOntario GenomicsGenome CanadaUniversity of OttawaMcGill UniversityNational Cancer InstituteUniversity of TorontoCarnegie Mellon UniversityEuropean Federation of Pharmaceutical Industries and AssociationsMerck KGaABayerBristol-Myers SquibbPfizerNational Science Foundation
KeywordsAffinitiesIn silicoBinding affinitiesChemistryLigand (biochemistry)Computational biologyLigand efficiencyLeucine-rich repeatKinaseBinding siteProtein kinase ABiochemistryStereochemistryCombinatorial chemistryBiologyReceptorGene

Abstract

fetched live from OpenAlex

High Resolution Image Download MS PowerPoint Slide The leucine-rich repeat kinase 2 (LRRK2) is the most mutated gene in familial Parkinson’s disease, and its mutations lead to pathogenic hallmarks of the disease. The LRRK2 WDR domain is an understudied drug target for Parkinson’s disease, with no known inhibitors prior to the first phase of the Critical Assessment of Computational Hit-Finding Experiments (CACHE) Challenge. A unique advantage of the CACHE Challenge is that the predicted molecules are experimentally validated in-house. Here, we report the design and experimental confirmation of LRRK2 WDR inhibitor molecules. We used an active learning (AL) machine learning (ML) workflow based on optimized free-energy molecular dynamics (MD) simulations utilizing the thermodynamic integration (TI) framework to expand a chemical series around two of our previously confirmed hit molecules. We identified 8 experimentally verified novel inhibitors out of 35 experimentally tested (23% hit rate). These results demonstrate the efficacy of our free-energy-based active learning workflow to explore large chemical spaces quickly and efficiently while minimizing the number and length of expensive simulations. This workflow is widely applicable to screening any chemical space for small-molecule analogs with increased affinity, subject to the general constraints of RBFE calculations. The mean absolute error of the TI MD calculations was 2.69 kcal/mol, with respect to the measured K D of hit compounds.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Simulation or modeling · Consensus signal: Simulation or modeling
GenreCandidate signal: Methods · Consensus signal: none
Teacher disagreement score0.005
Threshold uncertainty score0.011

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.030
GPT teacher head0.309
Teacher spread0.279 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSimulation or modeling
Domainnot available
GenreMethods

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Chemical Information and ModelingSame topicComputational Drug Discovery MethodsFrench-language works237,207